MERCK & CO Aktie

 

In the latest trading session, Merck (MRK) closed at $80.93, marking a -1.77% move from the previous day....

Merck eyes growth beyond Keytruda with PAH drug Winrevair, aiming to offset the looming loss of exclusivity in 2028....

Merck (MRK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report....

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its second-quarter 2025 sales and earnings conference call with institutional investors and analysts at 9:00 a.m. ET on Tuesday, July 29. During the call, company executives will provide an overview of Merck's performance for the quarter. Investors, journalists and the general public may access a live audio webcast of the call via this weblink. A replay of the webcast, along with the sales and earnings news release, supplemental financial disclosures and slides highlighting the results, will be available at www.merck.com. All participants may join the call by dialing (800) 369-3351 (U.S. and Canada Toll-Free) or (517) 308-9448 and using the access code 9818590. About Merck At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brough...

Merck's growing pipeline, with nearly 20 new launches ahead, is set to reshape its portfolio as Keytruda's 2028 patent expiry nears....

Robert F. Kennedy Jr.'s vaccine advisory committee recommended Merck & Co.'s shot to prevent newborns from getting RSV, alleviating some concerns that the new Department of Health and Human Services secretary's longstanding criticism of immunizations would interfere with its rollout....

MRK breaks above its 50-day average but near-term headwinds and weak China sales challenge the bullish case....

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Auslaufende Patente, geopolitische Risiken, Abschreibungen. Merck steht unter Druck, doch abseits der Schlagzeilen läuft das Geschäft erstaunlich gut....

Merck's Winrevair meets goal in a phase III study in newly diagnosed PAH patients, showing strong efficacy....

KENILWORTH (NJ) (dpa-AFX) - Merck & Co Inc. (MRK) Monday announced positive topline results from the Phase 3 HYPERION study evaluating Winrevair in adults with recently diagnosed pulmonary arteria......

Merck (MRK) closed at $79.29 in the latest trading session, marking a +1.29% move from the prior day....

Merck (MRK) concluded the recent trading session at $78.28, signifying a -3.31% move from its prior day's close....

Merck's Gardasil sales decline due to weak demand trends in China, with new launches expected to offset the downside....

According to the average brokerage recommendation (ABR), one should invest in Merck (MRK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?...

Das Instrument 6MK US58933Y1055 MERCK CO. DL-,01 EQUITY wird ex Dividende/Zinsen gehandelt am 16.06.2025 The instrument 6MK US58933Y1055 MERCK CO. DL-,01 EQUITY has its ex-dividend/interest day on 16.06.2025...

KENILWORTH (NJ) (dpa-AFX) - Merck Animal Health, a division of Merck & Co., Inc. (MRK), announced that the European Medicines Agency's Committee for Veterinary Medicinal Products (CVMP) issued a p......

Two new vaccine advisers tapped by Health and Human Services Secretary Robert F. Kennedy Jr. have served as paid expert witnesses for plaintiffs suing Merck & Co. over some of the drug company's inoculations targeting measles, mumps and cancer....

In the most recent trading session, Merck (MRK) closed at $80.32, indicating a -1.27% shift from the previous trading day....

Merck (MRK) closed at $81.35 in the latest trading session, marking a +2.55% move from the prior day....